The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview

被引:17
作者
M'Koma, Amosy E. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Meharry Med Coll, Sch Med, Dept Biochem Canc Biol Neurosci & Pharmacol, Nashville, TN 37208 USA
[2] Vanderbilt Univ, Sch Med, Dept Surg Colon & Rectal Surg, Nashville, TN 37232 USA
[3] Amer Soc Colon & Rectal Surg ASCRS, Arlington Hts, IL 60005 USA
[4] Amer Gastroenterol Assoc AGA, Bethesda, MD 20814 USA
[5] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr VICC, Nashville, TN 37232 USA
来源
GASTROINTESTINAL DISORDERS | 2019年 / 1卷 / 01期
关键词
gastrointestinal disorders; inflammatory bowel disease; ulcerative colitis; Crohn's disease; indeterminate colitis; inflammation; rural lifestyle; urbanization; diet; nutrition; environment; intestinal microbiota; dysbiosis; dysbacteriosis); genetics; ethnicity; innate immune system; adaptive; acquired immune system; FECAL MICROBIOTA TRANSPLANTATION; INVASIVE ESCHERICHIA-COLI; POPULATION-BASED COHORT; C-REACTIVE PROTEIN; MUCOSA-ASSOCIATED MICROBIOTA; EUROPEAN PROSPECTIVE COHORT; POLYUNSATURATED FATTY-ACID; SULFATE-REDUCING BACTERIA; AMBIENT AIR-POLLUTION; HUMAN GUT MICROBIOTA;
D O I
10.3390/gidisord1010007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The gastrointestinal system where inflammatory bowel disease occurs is central to the immune system where the innate and the adaptive/acquired immune systems are balanced in interactions with gut microbes under homeostasis conditions. This article overviews the high-throughput research screening on multifactorial interplay between genetic risk factors, the intestinal microbiota, urbanization, modernization, Westernization, the environmental influences and immune responses in the etiopathogenesis of inflammatory bowel disease in humans. Inflammatory bowel disease is an expensive multifactorial debilitating disease that affects thousands new people annually worldwide with no known etiology or cure. The conservative therapeutics focus on the established pathology where the immune dysfunction and gut injury have already happened but do not preclude or delay the progression. Inflammatory bowel disease is evolving globally and has become a global emergence disease. It is largely known to be a disease in industrial-urbanized societies attributed to modernization and Westernized lifestyle associated with environmental factors to genetically susceptible individuals with determined failure to process certain commensal antigens. In the developing nations, increasing incidence and prevalence of inflammatory bowel disease (IBD) has been associated with rapid urbanization, modernization and Westernization of the population. In summary, there are identified multiple associations to host exposures potentiating the landscape risk hazards of inflammatory bowel disease trigger, that include: Western life-style and diet, host genetics, altered innate and/or acquired/adaptive host immune responses, early-life microbiota exposure, change in microbiome symbiotic relationship (dysbiosis/dysbacteriosis), pollution, changing hygiene status, socioeconomic status and several other environmental factors have long-standing effects/influence tolerance. The ongoing multipronged robotic studies on gut microbiota composition disparate patterns between the rural vs. urban locations may help elucidate and better understand the contribution of microbiome disciplines/ecology and evolutionary biology in potentially protecting against the development of inflammatory bowel disease.
引用
收藏
页码:75 / 105
页数:31
相关论文
共 270 条
  • [31] The CREM gene is involved in genetic predisposition to inflammatory bowel disease in the Tunisian population
    Bouzid, Dorra
    Fourati, Hajer
    Amouri, Ali
    Marques, Isabel
    Abida, Olfa
    Haddouk, Samy
    Ben Ayed, Mourad
    Tahri, Nabil
    Penha-Goncalves, Carlos
    Masmoudi, Hatem
    [J]. HUMAN IMMUNOLOGY, 2011, 72 (12) : 1204 - 1209
  • [32] Ecotoxicology inside the gut: impact of heavy metals on the mouse microbiome
    Breton, Jerome
    Massart, Sebastien
    Vandamme, Peter
    De Brandt, Evie
    Pot, Bruno
    Foligne, Benoit
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2013, 14 : 62
  • [33] BROM B, 1968, South African Medical Journal, V42, P1099
  • [34] Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation
    Cader, M. Zaeem
    Kaser, Arthur
    [J]. GUT, 2013, 62 (11) : 1653 - 1664
  • [35] The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre Study
    Cantoro, Laura
    Di Sabatino, Antonio
    Papi, Claudio
    Margagnoni, Giovanna
    Ardizzone, Sandro
    Giuffrida, Paolo
    Giannarelli, Diana
    Massari, Alessandro
    Monterubbianesi, Rita
    Lenti, Marco Vincenzo
    Corazza, Gino Roberto
    Kohn, Anna
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 (08) : 975 - 980
  • [36] Emerging biologics in inflammatory bowel disease
    Chan, Heyson Chi-hey
    Ng, Siew Chien
    [J]. JOURNAL OF GASTROENTEROLOGY, 2017, 52 (02) : 141 - 150
  • [37] The emerging role of miRNAs in inflammatory bowel disease: a review
    Chapman, Christopher G.
    Pekow, Joel
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2015, 8 (01) : 4 - 22
  • [38] Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
    Chassaing, Benoit
    Koren, Omry
    Goodrich, Julia K.
    Poole, Angela C.
    Srinivasan, Shanthi
    Ley, Ruth E.
    Gewirtz, Andrew T.
    [J]. NATURE, 2015, 519 (7541) : 92 - U192
  • [40] The Influence of Second-Hand Cigarette Smoke Exposure during Childhood and Active Cigarette Smoking on Crohn's Disease Phenotype Defined by the Montreal Classification Scheme in a Western Cape Population, South Africa
    Chivese, Tawanda
    Esterhuizen, Tonya M.
    Basson, Abigail Raffner
    [J]. PLOS ONE, 2015, 10 (09):